Did you receive a notice from Novartis and Par Exforge? Did you receive a mail about a class action settlement about Novartis and Par Exforge price-fixing $30M Lawsuit? This review will help you partake in the class action settlement after confirming the authenticity of the mail.
What Is Novartis and Par Exforge price-fixing $30M Class Action Lawsuit?
Novartis has agreed to a $30 million settlement to end claims it engaged in a price-fixing scheme with company Par for the blood pressure medication commonly known as Exforge.
The case is In re: Novartis and Par Antitrust Litigation, Case No. 1:18-cv-04361, in the U.S. District Court for the Southern District of New York.
What Is This Class Action All About?
The lawsuit alleged Novartis, the manufacturer of Exforge, and Par, a generic pharmaceutical company, entered into an agreement where Novartis agreed not to sell an authorized generic version of Exforge until six months after Par began selling its generic version of Exforge.
In exchange, Par agreed to delay the launch of its generic Exforge product for approximately two years. The lawsuit alleges the companies violated certain state antitrust, consumer protection, and unjust enrichment laws, harming competition and causing people to overpay for brand and generic Exforge.
Novartis is a Swiss multinational pharmaceutical corporation based in Switzerland. It is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Par has declared bankruptcy and is not contributing to the settlement fund.
To be eligible to receive a payment if the settlement is approved, class members must complete and submit a valid claim form with evidence from their pharmacy or doctor to request their pro rata share of the net settlement fund.
Class members will not be responsible for calculating the amount they are entitled to receive. The settlement website is ExforgeAntitrustSettlement.com.
Who Is Eligible?
This settlement benefits all individuals who purchased or paid for brand and generic Exforge from Sept. 21, 2012, through June 30, 2018, in the District of Columbia, Arizona, California, Florida, Hawaii, Iowa, Maine, Michigan, Minnesota, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Dakota, Utah, Vermont, West Virginia or Wisconsin.
How To Be Part of This Settlement
To partake in this settlement, class member must submit a valid and timely claim on the settlement website by Aug. 18, 2023.
Class members who wish to exclude themselves from or object to the class action settlement must do so no later than Aug. 18, 2023.
What Is The Pay For This Settlement?
The pay for this settlement varies and the proof of purchase is the records from your pharmacy or a note from your doctor demonstrating that you bought Exforge or its generic.
Conclusion
As you submit your claim to the settlement website, just like BeReal App class action settlement we have reviewed, you’re doing so under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. The court has scheduled a fairness hearing for Oct. 3, 2023.
